CSL Limited CSL.AX Stock
CSL Limited Price Chart
CSL Limited CSL.AX Financial and Trading Overview
| CSL Limited stock price | 131.47 AUD |
| Previous Close | 123.06 AUD |
| Open | 121.99 AUD |
| Bid | 124 AUD x 0 |
| Ask | 124.33 AUD x 0 |
| Day's Range | 121.87 - 124.83 AUD |
| 52 Week Range | 90 - 273.45 AUD |
| Volume | 709.41K AUD |
| Avg. Volume | 1.84M AUD |
| Market Cap | 59.53B AUD |
| Beta (5Y Monthly) | 0.084 |
| PE Ratio (TTM) | 14.013529 |
| EPS (TTM) | 8.82 AUD |
| Forward Dividend & Yield | 4.26 (3.45%) |
| Ex-Dividend Date | March 10, 2026 |
| 1y Target Est | 139.08 AUD |
CSL.AX Valuation Measures
| Enterprise Value | 71.13B AUD |
| Trailing P/E | 14.013529 |
| Forward P/E | 13.77566 |
| PEG Ratio (5 yr expected) | 1.82 |
| Price/Sales (ttm) | 3.8637476 |
| Price/Book (mrq) | 2.253839 |
| Enterprise Value/Revenue | 4.616 |
| Enterprise Value/EBITDA | 14.695 |
Trading Information
CSL Limited Stock Price History
| Beta (5Y Monthly) | 0.084 |
| 52-Week Change | -53.54% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 273.45 AUD |
| 52 Week Low | 90 AUD |
| 50-Day Moving Average | 112.32 AUD |
| 200-Day Moving Average | 146.48 AUD |
CSL.AX Share Statistics
| Avg. Volume (3 month) | 1.84M AUD |
| Avg. Daily Volume (10-Days) | 1.26M AUD |
| Shares Outstanding | 478.91M |
| Float | 481.75M |
| Short Ratio | N/A |
| % Held by Insiders | 0.030% |
| % Held by Institutions | 40.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.92 |
| Trailing Annual Dividend Yield | 2.37% |
| 5 Year Average Dividend Yield | 160.00% |
| Payout Ratio | 0.45490003 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 9.06% |
| Operating Margin (ttm) | 31.64% |
| Gross Margin | 51.87% |
| EBITDA Margin | 31.41% |
Management Effectiveness
| Return on Assets (ttm) | 6.57% |
| Return on Equity (ttm) | 6.66% |
Income Statement
| Revenue (ttm) | 15.41B AUD |
| Revenue Per Share (ttm) | 31.84 AUD |
| Quarterly Revenue Growth (yoy) | -1.79% |
| Gross Profit (ttm) | 7.99B AUD |
| EBITDA | 4.84B AUD |
| Net Income Avi to Common (ttm) | 1.4B AUD |
| Diluted EPS (ttm) | 8.87 |
| Quarterly Earnings Growth (yoy) | -80.00000000000000000000000000000000% |
Balance Sheet
| Total Cash (mrq) | 1.14B AUD |
| Total Cash Per Share (mrq) | 2.38 AUD |
| Total Debt (mrq) | 11.14B AUD |
| Total Debt/Equity (mrq) | 54.44 AUD |
| Current Ratio (mrq) | 2.571 |
| Book Value Per Share (mrq) | 55.15035 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.6B AUD |
| Levered Free Cash Flow (ttm) | 1.85B AUD |
Profile of CSL Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 655 Elizabeth Street |
| ZIP | 3000 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29904 |
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Q&A For CSL Limited Stock
What is a current CSL.AX stock price?
CSL Limited CSL.AX stock price today per share is 131.47 AUD.
How to purchase CSL Limited stock?
You can buy CSL.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL Limited?
The stock symbol or ticker of CSL Limited is CSL.AX.
Which industry does the CSL Limited company belong to?
The CSL Limited industry is Biotechnology.
How many shares does CSL Limited have in circulation?
The max supply of CSL Limited shares is 478.91M.
What is CSL Limited Price to Earnings Ratio (PE Ratio)?
CSL Limited PE Ratio is 14.90589600 now.
What was CSL Limited earnings per share over the trailing 12 months (TTM)?
CSL Limited EPS is 8.82 AUD over the trailing 12 months.
Which sector does the CSL Limited company belong to?
The CSL Limited sector is Healthcare.
CSL Limited CSL.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P/ASX ALL AUSTRALIAN 200
AXAT
AU
|
9254.4 AUD 6464.83 USD |
+0.33
|
— — | 9223.6 AUD 6443.31 USD | 9290.9 AUD 6490.32 USD | — - | — — |
|
S&P/ASX 100
ATOI
AU
|
7783.7 AUD 5437.44 USD |
+0.27
|
— — | 7762.7 AUD 5422.77 USD | 7818.4 AUD 5461.68 USD | — - | — — |
|
ALL ORDINARIES
AORD
AU
|
9443.4 AUD 6596.86 USD |
+0.4
|
— — | 9405.4 AUD 6570.31 USD | 9473.9 AUD 6618.16 USD | — - | — — |
US Tech Developed Select Leaders
NQDMSLC
US
|
1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
|
S&P/ASX 300
AXKO
AU
|
9187.1 AUD 6417.81 USD |
+0.36
|
— — | 9154.2 AUD 6394.83 USD | 9221.1 AUD 6441.56 USD | — - | — — |
|
S&P/ASX 200 EQUAL WEIGHT [XEW]
AXEW
AU
|
2178.9 AUD 1522.11 USD |
+1.1
|
— — | 2155.3 AUD 1505.62 USD | 2181.9 AUD 1524.21 USD | — - | — — |
|
S&P/ASX ALL AUSTRALIAN 50
AXAF
AU
|
9053.8 AUD 6324.69 USD |
+0.12
|
— — | 9035.8 AUD 6312.12 USD | 9100.1 AUD 6357.04 USD | — - | — — |
|
S&P/ASX 20
ATLI
AU
|
5376.4 AUD 3755.78 USD |
<0.01
|
— — | 5366.5 AUD 3748.86 USD | 5410.7 AUD 3779.74 USD | — - | — — |
|
S&P/ASX 50
AFLI
AU
|
9063.3 AUD 6331.33 USD |
+0.14
|
— — | 9044.3 AUD 6318.06 USD | 9109.6 AUD 6363.67 USD | — - | — — |
|
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
|
S&P/ASX 200 Net Total Rtn
AXNT
AU
|
118804 AUD 82992.67 USD |
+0.36
|
— — | 118379.4 AUD 82696.05 USD | 119263.1 AUD 83313.38 USD | — - | — — |
|
S&P/ASX 200
AXJO
AU
|
9260.7 AUD 6469.23 USD |
+0.36
|
— — | 9227.8 AUD 6446.25 USD | 9296.7 AUD 6494.38 USD | — - | — — |
- {{ link.label }} {{link}}
